Caregen Co Ltd
KOSDAQ:214370
Caregen Co Ltd
Net Income (Common)
Caregen Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Net Income (Common)
₩35.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
Yuhan Corp
KRX:000100
|
Net Income (Common)
₩124.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
4%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Net Income (Common)
-₩32.9B
|
CAGR 3-Years
49%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Net Income (Common)
₩146.2B
|
CAGR 3-Years
130%
|
CAGR 5-Years
42%
|
CAGR 10-Years
13%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Net Income (Common)
-₩9.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Net Income (Common)
₩16.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
24%
|
See Also
What is Caregen Co Ltd's Net Income (Common)?
Net Income (Common)
35.3B
KRW
Based on the financial report for Mar 31, 2024, Caregen Co Ltd's Net Income (Common) amounts to 35.3B KRW.
What is Caregen Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
15%
Over the last year, the Net Income (Common) growth was 4%. The average annual Net Income (Common) growth rates for Caregen Co Ltd have been 3% over the past three years , 15% over the past five years .